共 32 条
- [31] Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways PHARMACEUTICAL BIOLOGY, 2022, 60 (01) : 1949 - 1959